Compare XBIT & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XBIT | PCYO |
|---|---|---|
| Founded | 2005 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.8M | 249.5M |
| IPO Year | 2015 | 1995 |
| Metric | XBIT | PCYO |
|---|---|---|
| Price | $2.20 | $10.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 36.5K | ★ 74.3K |
| Earning Date | 11-11-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 12.50 |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | ★ $1,227,787.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $30.47 | N/A |
| P/E Ratio | ★ N/A | $30.61 |
| Revenue Growth | N/A | ★ 171.54 |
| 52 Week Low | $2.09 | $9.71 |
| 52 Week High | $3.44 | $12.44 |
| Indicator | XBIT | PCYO |
|---|---|---|
| Relative Strength Index (RSI) | 47.52 | 46.74 |
| Support Level | $2.16 | $10.94 |
| Resistance Level | $2.48 | $11.03 |
| Average True Range (ATR) | 0.04 | 0.15 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 66.67 | 54.84 |
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in three business segments namely Water and wastewater resource development, Land development, and the Single-Family Rental Segment. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.